Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Authors:
- 25 November 2010
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 36 (3) , 342-347
Abstract
To assess the efficacy of contrast-enhanced ultrasonography (CEUS) with Sonovue in the evaluation of therapeutic response to radiofrequency ablation (RFA) of renal cell carcinoma (RCC).Keywords
This publication has 23 references indexed in Scilit:
- Operative Therapie des NierenzellkarzinomsAktuelle Urologie, 2010
- Current status of renal radiofrequency ablationCurrent Opinion in Urology, 2009
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008Ultraschall in der Medizin - European Journal of Ultrasound, 2008
- Immediate and long-term CT appearances following radiofrequency ablation of renal tumoursClinical Radiology, 2008
- Ultrasound contrast agents: An overviewEuropean Journal of Radiology, 2006
- The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigationsUltrasound in Medicine & Biology, 2006
- Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: Utility of contrast-enhanced agent detection imagingEuropean Journal of Radiology, 2005
- Radiofrequenzablation des Nierenzellkarzinoms unter MR-Bildgebung: Erste ErgebnisseRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2005
- Radiofrequency Ablation of Renal Cell Carcinoma: Part 1, Indications, Results, and Role in Patient Management over a 6-Year Period and Ablation of 100 TumorsAmerican Journal of Roentgenology, 2005
- Contrast–enhanced ultrasound of the kidneysEuropean Radiology Supplements, 2004